Biogen Inc (BIIB)

Index:

Nasdaq 100

$ 216.12
   
  • Change Today:
    $6.38
  • 52 Week High: $219.01
  • 52 Week Low: $122.68
  • Currency: US Dollars
  • Shares Issued: 146.80m
  • Volume: 1,155,165
  • Market Cap: $31,726m
  • RiskGrade: 259

Deal with Barclays    Trade now with Barclays Stockbrokers

Biogen Inc Overview

In November 2003, Biogen and IDEC Pharmaceuticals finalised their $6bn merger, creating Biogen Idec, the third-largest biotechnology company in the world. The company is now a global leader in the development, manufacturing, and commercialisation of novel therapies. Its major products include treatments for relapsing multiple sclerosis, certain B-cell non-Hodgkin's lymphomas and adult patients with moderate-to-severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn 15.7%
ROCE 17.0%
Latest F'cast
P/E 23.0
PEG n/a
Pr/Revenue 3.0
Pr/Book 1.6
Latest F'cast
Revenue 2.2%
PBT -18.3%
EPS -21.2%
DPS n/a

Biogen Inc Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 10,981.70 1,779.50 1,044.00¢ 23.0 n/a -58% n/a 0.0%
31-Dec-22 10,173.40 3,591.80 2,096.00¢ 13.2 0.1 +101% n/a 0.0%
31-Dec-23 9,835.60 1,296.80 802.00¢ 32.3 n/a -62% n/a 0.0%
31-Dec-24 9,675.90 1,906.00 1,121.00¢ 13.6 0.3 +40% n/a 0.0%
31-Dec-25 9,890.60 1,556.50 883.00¢ 19.9 n/a -21% n/a 0.0%

Biogen Inc Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 9,940.75 2,733.63 1,446.65¢ 14.9 0.2 +64% n/a 0.0%
31-Dec-27 10,164.69 3,032.17 1,633.17¢ 13.2 1.0 +13% n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Biogen Inc ShareCast News

Biogen to buy Apellis Pharmaceuticals in $5.6bn ... 31-Mar-2026 ShareCast
Biogen ups forecasts despite weak Alzheimer's dr... 20-Oct-2021 ShareCast
Biogen shares soar as FDA approves Alzheimer's d... 08-Jun-2021 ShareCast

Biogen Inc Top Newspaper Links

Elan says federal judge ruled it broke terms of ... 04-Sep-2009 Chicago Tribune
Johnson & Johnson Buys Access to an Alzheimer’s ... 03-Jul-2009 New York Times
Icahn Places Two Allies on the Biogen Idec Board 04-Jun-2009 New York Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Biogen Inc Market Data

Currency US Dollars
Share Price $ 216.12
Change Today $ 6.38
% Change 3.04 %
52 Week High $219.01
52 Week Low $122.68
Volume 1,155,165
Shares Issued 146.80m
Market Cap $31,726m
RiskGrade 259

What The Brokers Say

Strong Buy 8
Buy 6
Neutral 15
Sell 1
Strong Sell 0
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 02-Jul-2026

Time Volume / Share Price
16:00 216,016 @ $216.12
15:59 100 @ $216.13
15:59 100 @ $216.12
15:59 100 @ $216.07
15:59 100 @ $216.16

Top of Page